These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 28666669)

  • 21. Desmopressin and nocturnal voiding dysfunction: Clinical evidence and safety profile in the treatment of nocturia.
    Chung E
    Expert Opin Pharmacother; 2018 Feb; 19(3):291-298. PubMed ID: 29376448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of nocturia response to desmopressin treatment in elderly men with and without nocturnal polyuria in real-life practice.
    Chen SL; Huang YH; Hung TW; Ou YC
    Int J Clin Pract; 2016 May; 70(5):372-9. PubMed ID: 27039892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nocturia is often inadequately assessed, diagnosed and treated by physicians: results of an observational, real-life practice database containing 8659 European and US-American patients.
    Oelke M; Anderson P; Wood R; Holm-Larsen T
    Int J Clin Pract; 2016 Nov; 70(11):940-949. PubMed ID: 27753248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence, subtypes, and correlates of nocturia in the symptoms of Lower Urinary Tract Dysfunction Research Network cohort.
    Clemens JQ; Wiseman JB; Smith AR; Amundsen CL; Yang CC; Bradley MS; Kirkali Z; Agochukwu NQ; Cameron AP;
    Neurourol Urodyn; 2020 Apr; 39(4):1098-1107. PubMed ID: 32249998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Classification of nocturia by analyzing frequency volume chart and relations with international prostate symptom score in male patients with lower urinary tract symptoms in Korea.
    Choi YS; Kim JC; Kim YH; Choi JB; Park WH; Lee DH
    Investig Clin Urol; 2019 Jul; 60(4):267-274. PubMed ID: 31294136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower urinary tract symptoms in children and adolescents with Williams-Beuren syndrome.
    Sammour ZM; de Bessa J; Hisano M; Bruschini H; Kim CA; Srougi M; Gomes CM
    J Pediatr Urol; 2017 Apr; 13(2):203.e1-203.e6. PubMed ID: 27876405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The change of IPSS 7 (nocturia) score has the maximum influence on the change of Qol score in patients with lower urinary tract symptoms.
    Choi WS; Son H
    World J Urol; 2019 Apr; 37(4):719-725. PubMed ID: 30073391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tolterodine extended release in the treatment of male OAB/storage LUTS: a systematic review.
    Gacci M; Novara G; De Nunzio C; Tubaro A; Schiavina R; Brunocilla E; Sebastianelli A; Salvi M; Oelke M; Gravas S; Carini M; Serni S
    BMC Urol; 2014 Oct; 14():84. PubMed ID: 25348235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dutasteride Improves Nocturia but Does Not Lead to Better Sleep: Results from the REDUCE Clinical Trial.
    Kuhlmann PK; Fischer SC; Howard LE; Moreira DM; Andriole GL; Hopp ML; Roehrborn CG; Bliwise DL; Freedland SJ
    J Urol; 2021 Jun; 205(6):1733-1739. PubMed ID: 33605791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose Desmopressin and Tolterodine Combination Therapy for Treating Nocturia in Women with Overactive Bladder: A Double-blind, Randomized, Controlled Study.
    Rovner ES; Raymond K; Andruczyk E; Juul KV
    Low Urin Tract Symptoms; 2018 Sep; 10(3):221-230. PubMed ID: 28560762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
    Sand PK; Dmochowski RR; Reddy J; van der Meulen EA
    J Urol; 2013 Sep; 190(3):958-64. PubMed ID: 23454404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score.
    Fujimura T; Kume H; Nishimatsu H; Sugihara T; Nomiya A; Tsurumaki Y; Miyazaki H; Suzuki M; Fukuhara H; Enomoto Y; Homma Y
    BJU Int; 2012 May; 109(10):1512-6. PubMed ID: 21883834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nocturia: aetiology and treatment in adults.
    Dani H; Esdaille A; Weiss JP
    Nat Rev Urol; 2016 Oct; 13(10):573-83. PubMed ID: 27455894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. European Association of Urology Guidelines on the Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 2: Underactive Bladder, Bladder Outlet Obstruction, and Nocturia.
    Arlandis S; Bø K; Cobussen-Boekhorst H; Costantini E; de Heide M; Farag F; Groen J; Karavitakis M; Lapitan MC; Manso M; Arteaga SM; Nambiar AK; Riogh ANA; O'Connor E; Omar MI; Peyronnet B; Phé V; Sakalis VI; Sihra N; Tzelves L; van Poelgeest-Pomfret ML; van den Bos TWL; van der Vaart H; Harding CK
    Eur Urol; 2022 Jul; 82(1):60-70. PubMed ID: 35181193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevalence and risk factors of nocturia in China, South Korea, and Taiwan: results from a cross-sectional, population-based study.
    Chow PM; Liu SP; Chuang YC; Lee KS; Yoo TK; Liao L; Wang JY; Liu M; Sumarsono B; Jong JJ
    World J Urol; 2018 Nov; 36(11):1853-1862. PubMed ID: 29796775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fesoterodine for the Treatment of Nocturnal Urgency in Patients with Overactive Bladder Syndrome: An Analysis of Responders and Nonresponders.
    Khusid JA; Weiss JP; Carlsson MO; Mangan EK
    J Urol; 2017 Nov; 198(5):1119-1123. PubMed ID: 28479240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severity and bother of lower urinary tract symptoms among men aged 30-80 years: Tampere Ageing Male Urological Study (TAMUS).
    Pöyhönen A; Åkerla J; Häkkinen JT; Koskimäki J; Tammela TLJ; Auvinen A
    Scand J Urol; 2018 Aug; 52(4):296-301. PubMed ID: 30382800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic review and meta-analysis on the efficacy and tolerability of mirabegron for the treatment of storage lower urinary tract symptoms/overactive bladder: Comparison with placebo and tolterodine.
    Sebastianelli A; Russo GI; Kaplan SA; McVary KT; Moncada I; Gravas S; Chapple C; Morgia G; Serni S; Gacci M
    Int J Urol; 2018 Mar; 25(3):196-205. PubMed ID: 29205506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis.
    Gacci M; Ficarra V; Sebastianelli A; Corona G; Serni S; Shariat SF; Maggi M; Zattoni F; Carini M; Novara G
    J Sex Med; 2014 Jun; 11(6):1554-66. PubMed ID: 24708055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of age, metabolic syndrome, nocturnal polyuria and sleep disorders on nocturia.
    Sağlam HS; Gökkaya CS; Salar R; Memiş A; Adsan O
    Adv Clin Exp Med; 2013; 22(4):489-94. PubMed ID: 23986208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.